Pharmaceuticals New Zealand

New Zealand GERD Treatment Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

New Zealand GERD Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

New Zealand · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $83.1 Mn Placeholder estimate
Estimate 2025 $86.5 Mn 1.1% of the global market
Projected 2034 $124.2 Mn 43.6% Adds $37.7 Mn over 9 forecast years
CAGR 2025–2034 4.1% Faster than 8% of 160 Pharmaceuticals markets here
Key players 5
  • New Zealand is 1.14% of the global market.
  • In APAC, the largest is China at $676.3 Mn.
  • Fastest growing: India at 7% a year.
  • New Zealand ranks 5th of 10 by size in APAC.

Market size projection

New Zealand

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$37.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
GERD Treatment Market market size by year, New Zealand
YearMarket sizeChange that yearSince 2025
2024 (estimate) $83.1 Mn — —
2025 (base) $86.5 Mn +$3.4 Mn —
2026 (forecast) $90.0 Mn +$3.5 Mn +4.1%
2027 (forecast) $93.7 Mn +$3.7 Mn +8.4%
2028 (forecast) $97.6 Mn +$3.8 Mn +12.8%
2029 (forecast) $101.6 Mn +$4.0 Mn +17.4%
2030 (forecast) $105.7 Mn +$4.2 Mn +22.3%
2031 (forecast) $110.1 Mn +$4.3 Mn +27.3%
2032 (forecast) $114.6 Mn +$4.5 Mn +32.5%
2033 (forecast) $119.3 Mn +$4.7 Mn +37.9%
2034 (forecast) $124.2 Mn +$4.9 Mn +43.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

New Zealand GERD Treatment Market Analysis at a glance
Market size, 2025$86.5 Mn placeholder estimate
Forecast, 2034$124.2 Mn placeholder estimate
Growth (CAGR), 2025–20344.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTreatment, channel and end user (see all)
Key playersTakeda Pharmaceutical Company Ltd, AstraZeneca, Phathom Pharmaceuticals, Haleon PLC, Bayer AG (see all)
Regulator in New ZealandMedsafeSource: Medsafe. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The New Zealand GERD Treatment Market Analysis Executive Summary

GERD treatments relieve acid reflux and heartburn with acid-lowering medicines and procedures.

Key segments of the GERD Treatment market include treatment (Proton Pump Inhibitors, P-CABs and H2 Blockers) and channel (Prescription and Over-the-Counter).

Bar chart: New Zealand GERD Treatment market size, 2024–2034, placeholder estimates. $83.1 Mn in 2024, $86.5 Mn in 2025 and $124.2 Mn in 2034, 4.1% CAGR.
New Zealand GERD Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

New Zealand GERD Treatment Market Dynamics

Market Growth Drivers

Rising rates of gut and liver disease linked to diet, obesity and alcohol, more screening and new treatments are driving the GERD Treatment market.

Opportunity

Microbiome-based treatments, earlier testing and digital gut-health programmes give the GERD Treatment market room to grow.

Market Restraints

Late diagnosis, stigma, limited specialist access and high prices of new medicines hold back the GERD Treatment market.

Competitive Landscape for GERD Treatment Market in New Zealand

The GERD Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for GERD Treatment Market in New Zealand

GERD Treatment in New Zealand: rules and payment

Medsafe, part of the Ministry of Health, approves medicines before they can be sold.⁠[1] Pharmac decides which medicines and medical devices the public health system pays for.⁠[2]

[1] Medsafe. Checked 14 Nov 2026.

[2] Pharmac. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for GERD Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in New Zealand.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in GERD Treatment right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

GERD Treatment in context

New Zealand compared

  • Health spending per person: 5,022 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 17 countries we cover in APAC.[1]
  • Doctors: 3.61 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 2nd highest of the 17 countries we cover in APAC.[2]
  • People aged 65 and over: 17.6% of people (2025). World: 10.4% of people (2025). 5th highest of the 18 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the GERD Treatment market in New Zealand?
Placeholder estimate: about $86.5 Mn in 2025, rising to about $124.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the GERD Treatment market in New Zealand growing?
Placeholder estimate: about 4.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the GERD Treatment market report cover?
The report splits the market by treatment (Proton Pump Inhibitors, P-CABs, H2 Blockers, Antacids and more), channel (Prescription, Over-the-Counter) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the GERD Treatment market?
Key players include Takeda Pharmaceutical Company Ltd, AstraZeneca, Phathom Pharmaceuticals, Haleon PLC and Bayer AG.
What is driving the GERD Treatment market?
Rising rates of gut and liver disease linked to diet, obesity and alcohol, more screening and new treatments are driving the GERD Treatment market.
Who regulates GERD Treatment in New Zealand?
Medsafe, part of the Ministry of Health, approves medicines before they can be sold. Source: Medsafe. Checked 14 Nov 2026.
How is healthcare paid for in New Zealand?
Pharmac decides which medicines and medical devices the public health system pays for. Source: Pharmac. Checked 14 Nov 2026.
How much research is published on GERD Treatment?
PubMed lists 82 papers on GERD Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in New Zealand

See all

Related on gut health

See the topic